Cochrane Abstracts
5‐alpha‐reductase inhibitors for prostate cancer prevention
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"5‐alpha‐reductase Inhibitors for Prostate Cancer Prevention." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437821/all/5���������alpha���������reductase_inhibitors_for_prostate_cancer_prevention_Edited__no_change_to_conclusions_. Accessed 05 December 2023.
5‐alpha‐reductase inhibitors for prostate cancer prevention. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437821/all/5���������alpha���������reductase_inhibitors_for_prostate_cancer_prevention_Edited__no_change_to_conclusions_. Accessed December 5, 2023.
5‐alpha‐reductase inhibitors for prostate cancer prevention. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/437821/all/5���������alpha���������reductase_inhibitors_for_prostate_cancer_prevention_Edited__no_change_to_conclusions_
5‐alpha‐reductase Inhibitors for Prostate Cancer Prevention [Internet]. In: Cochrane Abstracts. [cited 2023 December 05]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437821/all/5���������alpha���������reductase_inhibitors_for_prostate_cancer_prevention_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - 5‐alpha‐reductase inhibitors for prostate cancer prevention
ID - 437821
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437821/all/5���������alpha���������reductase_inhibitors_for_prostate_cancer_prevention_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -
